Deadline Extended to April 1!
Call for 2015 HOPA Oncology Pharmacy Practice Management Program Proposals
Visit the Call for Speakers page for complete information.
HOPA Issues Statement on First Approved Biosimilar in the United States
HOPA is encouraged by the Food and Drug Administration's (FDA) approval of the first biosimilar product, Zarxio (filgrastim-sndz), in the United States, but strongly urges the FDA to develop a naming policy for approved biosimilars.
Read HOPA's press release here. View the HOPA issue brief related to biosimilars here.
Read ONS press release regarding the meeting of Safe Handling of Hazardous Drugs Association Stakeholders.
2015 HOPA RESEARCH FUND AWARD
The HOPA Research Committee announces a request for submission of letters of intent (LOIs) for the 2015 HOPA Research Award. A total of $50,000 in funding is available to be awarded in 2015. Visit the Research Grant page for complete information. Letters are due by Tuesday, May 26, 2015 (5:00 pm CST).
HOPA Joins ONS and ASCO in Joint Position Statement
HOPA has been working with ONS and ASCO on a joint position statement entitled, "Ensuring Healthcare Worker Safety When Handling Hazardous Drugs." The intent of this document is to ensure that there are policies and procedures in place to safeguard healthcare workers as well as their patients and minimize exposure risk when handling hazardous drugs. HOPA would like to thank Niesha Griffith, Dana McCauley, and Ray Mueller for their work in developing the statement.
Volunteer Online Portal for HOPA Committees Now OPEN for 2015-2016
The HOPA Volunteer Activity Center (VAC) is now open for the 2015-2016 committee year. Please visit the VAC and indicate your interest in volunteering for a committee, work group, or task force. This is also the place to let us know if you are interested in writing for HOPA News. The VAC will be open until March 31.
Senate Introduces Companion Bill to H.R. 592
Sens. Sherrod Brown (D-OH), Chuck Grassley (R-IA), Bob Casey (D-PA), and Mark Kirk (R-IL) have introduced S.314, a companion bill to H.R. 592, the Pharmacy and Medically Underserved Areas Enhancement Act.
HOPA continues to be actively involved in this initiative and President Michael Vozniak was on the Hill this week visiting the office of newly elected Congressman and fellow pharmacist, Buddy Carter (R-GA). HOPA is enthusiastic about Rep. Carter's election as he understands the unique needs of the profession and will serve as a champion on issues related to our industry.
A fact sheet on H.R. 592 is available here. Additionally, be on the lookout for an Action Alert asking your Members of Congress to support both the House and Senate bills.